... the class may present a more favorable risk-benefit profile as compared to interventions based on gene therapy, cell therapy and other novel approaches.
https://www.google.com/url?rct=j&sa=t&url=https://www.newswire.ca/news-releases/insilico-medicine-collaborates-with-gray-matter-to-fight-age-related-cognitive-decline-878096994.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGgyI0x7HHgoKSGTb5-QXu0wpWN0g
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.